Can glucose‐lowering medications improve outcomes in non‐diabetic heart failure patients? A Bayesian network meta‐analysis - Yeong, Trevor; Mai, Aaron Shengting; Lim, Oliver Z.H.; Ng, Cheng Han; Chin, Yip Han; Tay, Phoebe; Lin, Chaoxing; Muthiah, Mark; Khoo, Chin Meng; Dalakoti, Mayank; Loh, Poay‐Huan; Chan, Mark; et al. (ESC Heart Failure, 2022)
Keywords: Antidiabetics; Bias; Clinical trials; Diabetes; Ejection fraction; Generalized linear models; GLP-1 receptor agonists; Glucagon; Glucagon‐like peptide 1 receptor agonists; Glucose; Heart Failure; Humans; Meta-analysis; Metformin; Mortality; Original; Peptides; Sodium-Glucose Transporter 2 Inhibitors - therapeutic use; Sodium‐glucose cotransporter 2 inhibitors; Glucagon-like peptide 1 receptor agonists; Heart failure; Metformin; Sodium-glucose cotransporter 2 inhibitors